In a huge clinical achievement, Chinese researchers have effectively cured a patient's diabetes utilizing a groundbreaking cell therapy. This spearheading treatment was created by a group from Shanghai Changzheng Emergency clinic, the Centre for...
Oncocross, a pharmaceutical firm, declared on May 22nd that it has consented to a joint exploration arrangement with JW Pharmaceutical to foster new medications in view of the AI platform. Under this agreement, the two organizations will join...
Shanghai Henlius Biotech, Inc., a global biopharmaceutical firm, and Organon reported that the European Medicines Agency (EMA) has approved the marketing authorization applications (MAAs) for HLX14, an experimental Prolia and Xgeva (denosumab)...
Novotech Pty Ltd., the worldwide clinical contract research organization (CRO) that accomplices with biotech organizations to speed up the improvement of cutting edge and novel therapeutics at each stage, has marked a MoU with New Zealand Clinical...
West Pharmaceutical Services, Inc. (West), a global leader in innovative solutions for injectable drug administration, today announced it has relocated to a new office facility in Seoul and expanded its warehouse capacity. This is part of West's...
Eli Lilly, a pharmaceutical company, has declared it is funding one more $5.3 billion in an manufacturing plant in Lebanon, Indiana, to support the assembling of its exceptionally famous weight reduction drug Zepbound, diabetes treatment Mounjaro...
The US Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to lead clinical candidate VCN-01 in combination with gemcitabine and nab-paclitaxel to improve progression-free survival and overall survival in patients with...
Oxford Nanopore Technologies (Oxford Nanopore) has announced the introduction of a new Pharmacogenomics (PGx) Beta Programme to promote personalized medicine. The program combines Twist Bioscience's next generation sequencing (NGS) target...
Biocon Ltd said it has marked a exclusive licensing and supply concurrence with South Korea's Handok for commercialisation of its complex drug product, synthetic Liraglutide, utilized in the therapy of constant weight management. As per the...
Nona Biosciences, a worldwide biotechnology firm that offers a complete solution from “Idea to IND†(I to ITM), going from target approval and neutralizer disclosure through preclinical exploration, reported that it has gone into a license...
, CDSCO.jpg)
.jpg)